Medulloblastoma, while most commonly associated with children, can also occur in adults, although it is much rarer. In adults, medulloblastoma accounts for less than 1% of all primary brain tumors
Dendritic cells are antigen-presenting cells (APCs) essential for triggering T cell responses. They capture antigens from pathogens or tumor cells and process them into smaller fragments.
Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person.
The main principle of this treatment is the restoration of the body's own defenses, the immune system, and nonspecific antitumor mechanisms.
Dendritic cell therapy has become a component of modern immunotherapy for osteosarcoma, offering hope to patients at different stages of the disease
Immunotherapy for melanoma is the treatment of choice for patients with metastatic tumors, resistance to chemotherapeutic agents, and disease recurrence after the successful initial treatment.
Advances in treating lung cancer have led to improved survival rates, thereby extending the life expectancy of many cancer patients.
Dendritic cell therapy represents a transformative advancement in immunotherapy, redefining cancer treatment by empowering the immune system to precisely target malignant cells.
Cancer treatment with dendritic cells is indicated even for those patients who have not responded to all other types of therapy.
This is a common mechanism that provides cancer cells an escape from the innate immune system. Several therapeutics directed to CD47 or SIRPα have entered early clinical trials in recent years
Germany has become a global leader in cancer treatment, transforming many oncological diseases from terminal to manageable conditions.
Radiation therapy, along with chemotherapy and surgery, is one of the most powerful tools we use to treat cancer. Radiation therapy, along with chemotherapy and most powerful tools we use to treat cancer.
Lung cancer is the most common group of malignant tumors in the world, which develops from cells in the lungs and bronchi. It develops 10% more often in men than in women.
Thyroid cancer is not the most common disease. More than 120,000 cases of thyroid cancer are diagnosed around the world every year, which is 1% of all malignant tumors.
Brain cancer is a group of malignant oncological pathologies when a tumour arises from the brain tissues or its membranes. Usually this is characterised by an unfavourable prognosis.
Our benefits:
.webp)
.webp)
 (1).webp)
 (1).webp)
